{
  "id": "621ec0313a8413c65300005e",
  "type": "factoid",
  "question": "What class of drugs is commonly associated with Drug-induced interstitial lung disease (DIILD)?",
  "ideal_answer": "[' Numerous agents including cytotoxic and noncytotoxic drugs have the potential to cause pulmonary toxicity.']",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/2185802",
    "http://www.ncbi.nlm.nih.gov/pubmed/34177523",
    "http://www.ncbi.nlm.nih.gov/pubmed/1327232",
    "http://www.ncbi.nlm.nih.gov/pubmed/28050004",
    "http://www.ncbi.nlm.nih.gov/pubmed/24231065",
    "http://www.ncbi.nlm.nih.gov/pubmed/8765915",
    "http://www.ncbi.nlm.nih.gov/pubmed/10992015",
    "http://www.ncbi.nlm.nih.gov/pubmed/22189216",
    "http://www.ncbi.nlm.nih.gov/pubmed/17545850",
    "http://www.ncbi.nlm.nih.gov/pubmed/31963908",
    "http://www.ncbi.nlm.nih.gov/pubmed/32598798",
    "http://www.ncbi.nlm.nih.gov/pubmed/30326612",
    "http://www.ncbi.nlm.nih.gov/pubmed/29631763",
    "http://www.ncbi.nlm.nih.gov/pubmed/30521972",
    "http://www.ncbi.nlm.nih.gov/pubmed/22896776",
    "http://www.ncbi.nlm.nih.gov/pubmed/32874590",
    "http://www.ncbi.nlm.nih.gov/pubmed/31584970",
    "http://www.ncbi.nlm.nih.gov/pubmed/20298401"
  ],
  "snippets": [
    {
      "text": "The problem of the drug induced pulmonary toxicity (cytotoxic and non-cytotoxic drugs) is discussed.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/1327232",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "ulmonary drug toxicity is increasingly being diagnosed as a cause of acute and chronic lung disease. Numerous agents including cytotoxic and noncytotoxic drugs have the potential to cause pulmonary toxicity",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/10992015",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Cytotoxic agents may cause interstitial or eosinophilic pneumonitis, alveolar proteinosis, pulmonary venous occlusive disease, pulmonary fibrosis, pneumothorax, or pulmonary oedema",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/2185802",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The cytotoxic drugs which are most often implicated in causing this are bleomycin, methotrexate, cyclophosphamide and busulfan. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/8765915",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Cytotoxic drugs are the most common cause of toxic lung disease.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/8765915",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "er drugs, followed by rheumatology drugs, amiodarone and antibiotics, were the most common causes of DIILD. The",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30326612",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Drug-induced interstitial lung disease (DIILD) is a serious side effect of chemotherapy in cancer patients with an extremely high mortality rate.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31584970",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Furthermore, in a subgroup analysis of epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor (TKI)-induced interstitial lung disease (ILD), we observed seven candidate SNVs that were possibly associated with ILD (P < 0.00001).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31584970",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Drug-induced interstitial lung disease (DI-ILD) is a rare, yet life-threatening complication associated with tyrosine-kinase inhibitor (TKI) therapy. Thi",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34177523",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Drug-induced interstitial lung disease associated with dasatinib coinciding with active tuberculosis",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32874590",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "s was added. It is known that drug-induced ILD and susceptibility to infection associated with dasatinib occur in a dose-dep",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32874590",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "INTRODUCTION: The study objective was to determine the incidence and characteristics of drug-induced interstitial lung disease (ILD) associated with an orally available small-molecule tyrosine kinase inhibitor, crizotinib, in a real-world clinic",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30521972",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "INTRODUCTION: Although gefitinib used for the treatment of non-small-cell lung cancer is a well-known cause of interstitial lung disease (ILD), few case reports on erlotinib-induced ILD have",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20298401",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Drug-induced interstitial lung disease (DILD) can be caused by chemotherapeutic agents, antibiotics, antiarrhythmic drugs, and immunosuppressive agents.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22896776",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "INTRODUCTION: A rare but serious complication of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) therapy is a lung injury syndrome commonly referred to as a drug-induced interstitial lung ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17545850",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "BACKGROUND: Treatment of rheumatoid arthritis (RA)-related interstitial lung disease (ILD) is challenging, and many conventional and biologic disease-modifying anti-rheumatic drugs (DMARDs) have been associated with ILD development or ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31963908",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "OBJECTIVE: To review published cases of induced or exacerbated interstitial lung disease (ILD) in rheumatoid arthritis (RA) associated with non-biologic disease-modifying antirheumatic drugs (nbDMARDs) and biologics and to discuss clinical implications in daily practice.METHODS: We performed a systematic literature review from 1975 to July 2013 using Medline, Embase, Cochrane, and abstracts from the ACR 2010-2012 and EULAR 2010-2",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24231065",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "13 annual meetings. Case reports and series that suggest a causative role of nbDMARDs (methotrexate [MTX], leflunomide [LEF], gold, azathioprine [AZA], sulfasalazine [SSZ], and hydroxychloroquine [HCQ]) and biologic agents (TNF inhibitors [TNFi], rituximab [RTX], tocilizumab [TCZ], abatacept [ABA], and anakinra) in causing ILD or worsening a pre-existing ILD in RA pat",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24231065",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Drugs that are more commonly associated with lung toxicity include nitrofurantoin, amiodarone, and chemotherapeutic agents such as bleomycin and methotrexate.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29631763",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Drug-induced interstitial lung disease (D-ILD) can be caused by various drugs, including antibiotics, amiodarone, antitumor, rheumatological and non-steroidal anti-inflammatory drugs.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32598798",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "cytotoxic drugs"
}